Factors Related to Gemcitabine-induced Phlebitis
نویسندگان
چکیده
منابع مشابه
Peripheral intravenous catheter-related phlebitis and related risk factors.
INTRODUCTION Peripheral intravenous catheter-related phlebitis is a common and significant problem in clinical practice. This study aims to investigate the incidence of phlebitis and to evaluate some important related factors. METHODS 300 patients admitted to medical and surgical wards of hospitals in Semnan, Iran from April 2003 to February 2004 were prospectively studied. Variables evaluate...
متن کاملPostinfusion Phlebitis: Incidence and Risk Factors
Objective. To document the incidence of postinfusion phlebitis and to investigate associated risk factors. Design. Analysis of existing data set from a large randomized controlled trial, the primary purpose of which was to compare routine peripheral intravascular catheter changes with changing catheters only on clinical indication. Participants and Setting. Patients admitted to a large, acute g...
متن کاملPeripheral intravenous catheter related phlebitis and its contributing factors among adult population at KU Teaching Hospital.
BACKGROUND Peripheral intravenous catheter-related phlebitis is a common and significant problem in clinical practice. This study was carried out to determine the occurrence of peripheral intravenous catheter related phlebitis and to define the possible factors associated to its development. MATERIALS AND METHODS Prospective observational study was carried out on 230 clients who were under fi...
متن کاملRelated factors to continued breastfeeding in infants
Introduction: Breast milk is the best nutrition for infants. Although feeding mostly begins with breast milk but its continuation is ignored in some cases. In this regard, identification of related factors to breastfeeding is important. Objective: The purpose of this study is to determine related factors to continuing breastfeeding in hospitalized infants. ...
متن کاملGemcitabine-induced pulmonary toxicity.
BACKGROUND Gemcitabine is the only approved cytotoxic agent for the treatment of pancreatic cancer by the Food and Drug Administration. In addition, gemcitabine is also commonly used for the management of breast, ovarian, and non-small cell lung cancer. Myelosuppression is the most common toxicity of gemcitabine therapy. Pulmonary toxicities due to gemcitabine have, however, been reported. Dysp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Palliative Care Research
سال: 2018
ISSN: 1880-5302
DOI: 10.2512/jspm.13.187